Full Text View
Tabular View
Study Results
Related Studies
Efficacy and Safety of XP12B in Women With Menorrhagia
This study has been completed.
Study NCT00401193   Information provided by Ferring Pharmaceuticals

First Received on November 9, 2006.   Last Updated on June 9, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Menorrhagia
Heavy Menstrual Bleeding
Additional conditions recognized in this trial
Hemorrhage
More general conditions related to this trial
Genital Diseases, Female
Menstruation Disturbances
Pathologic Processes
Uterine Diseases
Uterine Hemorrhage
Interventions listed in this trial
Tranexamic acid tablets
Placebo tablets
Additional drug interventions recognized in this trial
Tranexamic Acid
More general drug interventions related to this trial
Antifibrinolytic Agents
Coagulants
Fibrin Modulating Agents
Hematologic Agents
Hemostatics
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Ferring Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services